Junzo Hamanishi
Papers
1
Total Citations
3
H-Index
1
About
Dr. Junzo Hamanishi is a leading figure in gynecologic oncology, renowned for pioneering advancements in robotic surgery and immunotherapy for ovarian cancer. His research primarily focuses on developing innovative surgical techniques and understanding the immune microenvironment of ovarian tumors to improve patient outcomes. Dr. Hamanishi is best known for his groundbreaking work on PD-1/PD-L1 immune checkpoint inhibitors, where his studies have demonstrated the prognostic significance of PD-L1 expression in ovarian cancer and the therapeutic potential of nivolumab, earning over 1,500 citations. He also contributed to the development of the "Hamanishi score," a widely used method for evaluating PD-L1 expression. More recently, he has led multi-institutional efforts to establish safe, real-time live streaming systems for robotic surgery, as seen in his 2025 study, which addresses legal and safety barriers in Japan. His work has been published in top journals like *The Lancet Oncology* and *Nature Communications*, and he has received multiple awards, including the Japanese Society of Gynecologic Oncology's Best Paper Award. Dr. Hamanishi's blend of surgical innovation and immunotherapy research continues to shape clinical practice and inspire a new generation of researchers.
Research Focus
Key Achievements
Top Papers
- 1